252 related articles for article (PubMed ID: 19747007)
1. Emerging treatments in cystic fibrosis.
Jones AM; Helm JM
Drugs; 2009 Oct; 69(14):1903-10. PubMed ID: 19747007
[TBL] [Abstract][Full Text] [Related]
2. New and Emerging Treatments for Cystic Fibrosis.
Barry PJ; Jones AM
Drugs; 2015 Jul; 75(11):1165-75. PubMed ID: 26091951
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis: a review of pulmonary and nutritional therapies.
Amin R; Ratjen F
Adv Pediatr; 2008; 55():99-121. PubMed ID: 19048729
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
Pettit RS
Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
[TBL] [Abstract][Full Text] [Related]
5. The Evolution of Cystic Fibrosis Care.
Pittman JE; Ferkol TW
Chest; 2015 Aug; 148(2):533-542. PubMed ID: 25764168
[TBL] [Abstract][Full Text] [Related]
6. New and emerging therapies for pulmonary complications of cystic fibrosis.
Tonelli MR; Aitken ML
Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
[TBL] [Abstract][Full Text] [Related]
7. Emerging drug treatments for cystic fibrosis.
Zeitlin PL
Expert Opin Emerg Drugs; 2003 Nov; 8(2):523-35. PubMed ID: 14662004
[TBL] [Abstract][Full Text] [Related]
8. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.
Proesmans M; Vermeulen F; De Boeck K
Eur J Pediatr; 2008 Aug; 167(8):839-49. PubMed ID: 18389279
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
Perrem L; Ratjen F
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options for hydrating airway mucus in cystic fibrosis.
Tildy BE; Rogers DF
Pharmacology; 2015; 95(3-4):117-32. PubMed ID: 25823699
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.
Kreindler JL
Pharmacol Ther; 2010 Feb; 125(2):219-29. PubMed ID: 19903491
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapies in cystic fibrosis.
Anderson P
Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
[TBL] [Abstract][Full Text] [Related]
13. Effect of duramycin on chloride transport and intracellular calcium concentration in cystic fibrosis and non-cystic fibrosis epithelia.
Oliynyk I; Varelogianni G; Roomans GM; Johannesson M
APMIS; 2010 Dec; 118(12):982-90. PubMed ID: 21091780
[TBL] [Abstract][Full Text] [Related]
14. Update on new pulmonary therapies.
Retsch-Bogart GZ
Curr Opin Pulm Med; 2009 Nov; 15(6):604-10. PubMed ID: 19696677
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for cystic fibrosis: what's in the pipeline?
Frerichs C; Smyth A
Expert Opin Pharmacother; 2009 May; 10(7):1191-202. PubMed ID: 19405793
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
17. Potential for antioxidant therapy of cystic fibrosis.
Cantin AM
Curr Opin Pulm Med; 2004 Nov; 10(6):531-6. PubMed ID: 15510062
[TBL] [Abstract][Full Text] [Related]
18. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
Jiang Q; Engelhardt JF
Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of Moli1901 in patients with cystic fibrosis.
Grasemann H; Stehling F; Brunar H; Widmann R; Laliberte TW; Molina L; Döring G; Ratjen F
Chest; 2007 May; 131(5):1461-6. PubMed ID: 17494794
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
